DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Remogliflozin etabonate
Remogliflozin etabonate
CDR Clinical Review Report for Soliqua
Download Product Insert (PDF)
Remogliflozin Etabonate, a Selective Inhibitor of the Sodium-Glucose
Sno. Rc No Item No. Item Name and Description Unit Annual Turnover
Exploring Glycosuria As a Mechanism for Weight and Fat Mass Reduction. a Pilot Study with Remogliflozin Etabonate and Sergliflozin Etabonate in Healthy Obese Subjects
(SGLT2) Inhibitors: a Systematic Review and Meta-Analysis
Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose
Canagliflozin, Dapagliflozin and Empagliflozin Monotherapy for Treating Type 2 Diabetes: Systematic Review and Economic Evaluation
Glenmark Receives Approval for Combination of Remogliflozin Etabonate and Metformin Hydrochloride for Adults with Type 2 Diabetes in India
BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available
Download Product Insert (PDF)
Adverse Effects and Safety of SGLT2 Inhibitor Use Among Patients with Type 2 Diabetes: Findings from RCT Evidence
Reniva Monograph
Sodium-Dependent Glucose Cotransporters
A Novel Analytical Method for the Simultaneous Estimation of Remogliflozin and Metformin Hydrochloride by Uplc / Pda in Bulk and Formulation
DIABETOLOGY SGLT2 Inhibitors: a Novel Therapy for Type 2 Diabetes Mellitus
Recommendations of the SEC (Endocrinology & Metabolism) Made in Its 66Th Meeting Held on 01.07.2020 at CDSCO HQ New Delhi: S
Drugs in Pipeline for Type-2 Diabetes R Mahajan, K Gupta
Top View
Sodium Glucose Co Transporter 2 (SGLT2) Inhibitors: a New Sword for the Treatment of Type 2 Diabetes Mellitus
The Sodium/Glucose Co-Transporter Inhibitors Are a Growing Repository
Novel Therapeutic Advancements in Type 2 Diabetes
Pharmacokinetics and Pharmacodynamics of the SGLT2 Inhibitor
Novel Treatments for Type 2 Diabetes
Safety, Pharmacokinetics and Pharmacodynamics of Remogliflozin
Appendix – Literature Search & In-Excluded Studies
A Real-World Clinical Experience on the Effectiveness of Remogliflozin Etabonate in Management of Indian Patients with Type II Diabetes Mellitus
International Journal of Diabetes in Developing Countries Incorporating Diabetes Bulletin
2012/062698 Al
Discovery Awaits You at the 81ST Scientific Sessions
Science Report 2011
Burden of Disease in 2013 Type 2 DM Glucose Management Goals
The Effects of Sodium-Glucose Co-Transporter-2 Inhibitors (SGLT
2019 Medicines in Development for Diabetes and Related Conditions
Tepzz 59Z6¥4B T
The Leading Source of Diabetes Business News Forward
Development and Validation of Rapid RP-HPLC and Green Second
Biocatalyzed Synthesis of Antidiabetic Drugs: a Review
A Complete Review of Empagliflozin
Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis
Assessment of Remogliflozin Etabonate, a Sodium-Dependent
2016 Medicines in Development for Diabetes and Related Conditions
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors from Natural Products: Discovery of Next-Generation Antihyperglycemic Agents